Construction of Bispecific Aptamer-Drug Conjugate by a Hybrid Chemical and Biological Approach

Bioconjug Chem. 2020 May 20;31(5):1289-1294. doi: 10.1021/acs.bioconjchem.0c00071. Epub 2020 Apr 7.

Abstract

Bispecific aptamer-drug conjugates (BsApDC) may improve the efficacy of drugs by enhancing cellular internalization and targeted delivery. Nevertheless, the synthesis of single-molecular BsApDC has not yet been reported, and it could be thwarted by synthetic challenges. Herein we report a general approach to synthesize a BsApDC hybridized chemical and biological method. Primers incorporated with 5-Fluorouracil (5-FU), 10-Hydroxycamptothecin, and Maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl-monomethyl auristatin E(vcMMAE) were prepared by chemical synthesis, which were converted to corresponding ApDCs efficiently by enzymatic reaction. Biological studies revealed that BsApDC binds with target cells with enhanced internalization and better inhibitory activity, demonstrating the potential of BsApDCs for targeted tumor therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aminobenzoates / chemistry
  • Aptamers, Nucleotide / chemistry*
  • Camptothecin / analogs & derivatives
  • Camptothecin / chemistry
  • Cell Line, Tumor
  • Fluorouracil / chemistry
  • Humans
  • Oligopeptides / chemistry
  • Pharmaceutical Preparations / chemistry*

Substances

  • Aminobenzoates
  • Aptamers, Nucleotide
  • Oligopeptides
  • Pharmaceutical Preparations
  • auristatin
  • 10-hydroxycamptothecin
  • Fluorouracil
  • Camptothecin